So much Good News, 2020 the Year of BIEL!! #1)

New Post Public Reply Private Reply Replies (1) Message Board
swordfish
946
So much Good News, 2020 the Year of BIEL!!

#1) 12/31/2019 - Keith Nalepka, "As 2019 ends, thank you shareholders. 2020 will be BIELs year. Guaranteed. This will be the year we change things, deals done and Actipatch moved forward. Don’t be confused, this is not the same old BIEL. This team is competent, capable and crushing it."
#ihatelosing #teamBIEL

https://twitter.com/keith_nalepka/status/1212029682931175425

<<< a VP and Board of Directors Member does not make this kind of statement unless multiple things are already ‘In The Bag’, KW re-tweeted this post so it also has the CEOs’ blessing>>>

#2) 12/19/2019 - Keith Nalepka, "Today with our Service Disabled Vet partner, Vetguard Supply LLC, we added the McGuire VA as a new account. This is a huge win for us to work through a service disabled vet company to get our product all across the country."

#notdoneyet #12daysofdeals #bielteam #fillingstockings

https://twitter.com/keith_nalepka/status/1208013335557496832

<<< McGuire is an enormous healthcare facility with more than 1 million sq ft of buildings and has 200,000 Veterans in its service area>>>

#3) December 2019 - 29,500 Devices Shipped; Mundipharma Singapore 15,000, Mundipharma Philippines 7,000, Pharmalink UAE 7,500

<<< Depending on the exact Distributor pricing $230k – 330k out the door in one month, the best month for BIEL in several years>>>

#4) 12/10/2019 - "We received the official ISO 13485:2016 certificate from our registrar. This certification is the latest quality management system being utilized in the global medical device industry and will boost the Company’s business credentials. The certificate is valid until December 10, 2022 (3 years) and will be subject to an audit annually.

<<< this is a major regulatory certification used around the world and is the foundation for many government import clearances, completed>>>

#5) 11/15/2019 – BIEL is pleased to announce that after seeking legal counsel a Board of Directors and Company officers have been appointed/re-affirmed.

<<< New Management team at BIEL, New Business plan focusing on OEM Partners, new way of treating Partners, this is BIEL 2.0, ready to close deals and ship product>>>

#6) 11/25/2019 - "Endonovo Therapeutics Inc. filed for Voluntarily Dismissal of its lawsuit against BioElectronics Corp., without prejudice. This move follows Jurisdictional Discovery paperwork filed on November 19, 2019 by the legal counsel representing BioElectronics. BioElectronics is considering its legal options against Endonovo, while prioritizing its resources on closing deals and increasing sales."

<<< this removes a significant burden from BIEL's plate, legal costs should be recoverable from ENDV who also filed 3 other frivolous patent lawsuits against other companies>>>

#7) 10/02/2019 – “Bioelectronics Corp is pleased to announce the publication of a study in the journal Pain Research and Management, titled “A Prospective Six-Month Study of Chronic Pain Sufferers: A Novel OTC Neuromodulation Therapy”. The study demonstrated that users who experience pain relief after using ActiPatch® for 7-days, continued to experience this relief over at least 6-months when ActiPatch® use is continued.”

http://www.bielcorp.com/bioelectronics-announ...onic-pain/

<<< some missed the importance of this study, many drug based pain relievers lose some of their effect when used for extended periods, this means upping the dose or changing drugs, ActiPatch does not have this issue>>>

#8) 6/28/2019 – RecoveryRx receives FDA 510k Clearance for “Adjunctive treatment of postoperative pain”.

https://www.globenewswire.com/news-release/20...erapy.html

<<< there are 25 million surgeries every year in the US and RecoveryRx can be used on them all, from Head to Toe. With RecoveryRx, exact same device as ActiPatch, Cleared for Full Body how can the FDA deny ActiPatch the same Full Body Clearance?>>>

#9) 07/10/2019 – Keith Nalepka is Interviewed on the Stock Day Show.

https://audioboom.com/posts/7311685-the-stock...-clearance.

<<< a wealth of information in this interview, if you have not listened to it you need to>>>

#10) 5/3/2019 - 'I've cured my chronic back pain with £19 patch - but NHS won't prescribe it'

https://www.mirror.co.uk/news/uk-news/ive-cur...n-14985643

<<< this UK Mirror feature article was free promotion, thousands of dollars worth, for BIEL and places pressure on the NHS to make ActiPatch Available to more patients>>>

#11) 03/14/2019 – Mundipharma brings Dr. Sree Koneru to Australia to present Clinical Evidence on the ActiPatch at the Australian Pharmacy Conference.

https://www.mundipharma.com.au/us-expert-pres...actipatch/

<<< further evidence that Mundipharma has gone ‘All In’ with ActiPatch>>>

#12) 11/15/2018 - Mundipharma adds 5 countries to its ActiPatch Distributorships, Singapore, Malaysia, Thailand, Indonesia and the Philippines.

<<< Mundipharma adds 5 countries to the initial Australia/New Zealand Distributorship Deal, they obviously like/need ActiPatch, they need to show that they promote pain relievers other than Opioids>>>

#13) 11/06/2018 - Pharmacy 4 Less CEO promotes ActiPatch on Australian TV Show.

https://www.youtube.com/watch?v=CvnUFUN8GPA

<<< this is a prime example of what having a Partner with the resources of Mundipharma does for ActiPatch>>>

#14) 7/23/2018 - Mundipharma has acquired the exclusive distribution rights for ActiPatch in Australia and New Zealand.

https://www.mundipharma.com.au/mundipharma-br...y-devices/

<<< Mundipharma had to buy out the existing distributor, Evomed, to get the distribution rights to ActiPatch>>>

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rain Agent Vaults: Revolutionizing Payments with AI

Updated Category News Views 123

Innovative Payments with AI Power Alright, folks, Rain's gone and done something that's probably going to shake things up in the payments world—'cause they've given AI agents the ability to handle money like never before. We're not just talking about some run-of-the-mill integration here. This is a genuine game changer, promising to make agents as financially savvy as...

Continue Reading
ProBio, AbTis Forge Bond for Next-Gen Oncology ADCs

Updated Category News Views 99

Deal or No Deal: ProBio's New Licensing Agreement In the ever-evolving realm of biopharmaceuticals, ProBio's recent handshake with South Korea's AbTis is stirring the pot. The shot-callers at ProBio are passing the baton to AbTis, giving them a crack at developing a thumping new therapeutic antibody asset aimed squarely at oncology targets. Pretty slick move if you ask...

Continue Reading
Alogent's Unify Snags Award for Innovation and Impact

Updated Category News Views 104

Innovation That Captures Attention Alogent sure did grab the spotlight with their Unify platform walking away with a Credit Union Times Luminaries Award. The name of the game here is deposit processing innovation—the kind of buzz that turns heads in the banking world. This recognition isn't just another plaque for the lobby; it's a testament to a significant stamp on...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 122

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
FirstDigital Expands Fiber Network in Utah and Arizona

Updated Category News Views 86

Weaving a Web of Connectivity Let's talk about FirstDigital putting its shoulder to the wheel in Utah and Arizona. They're expanding their redundant fiber network to rope in more businesses under their umbrella of connectivity. This ain't just another dry IT endeavor—it's about building a safety net for our ever-connected world. The Stakes of Network Disruption You know...

Continue Reading
Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Updated Category News Views 73

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 104

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
Bakersfield Sees Spike in Crashes Post Time Change

Updated Category News Views 83

Evening Darkness and Safety Concerns Folks, it seems Bakersfield streets transform into a battlefield once the clock falls back. With darkness creeping in earlier, those evening hours right after the time change see a sobering uptick in accidents. According to an analysis by Chain | Cohn | Clark, pedestrian and bicyclist crashes from 5 to 7 p.m. double. It's not just...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 5

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
Zephyr's Alto Hood: Redefining Kitchen Versatility

Updated Category News Views 75

An Artist in the Kitchen Who knew a kitchen hood could be a canvas, right? Zephyr, always a punch above the ordinary in kitchen design, has pulled another rabbit out of their hat with the Alto Wall Custom Hood. Forget blending in; this piece is about standing out and shouting style—all while keeping your cooking area fresh. Options Galore The Alto Hood isn't about...

Continue Reading

Top 5 Most Recently Viewed Articles

Constellation Brands Schedules Earnings Call for Q2 2026

Updated Category News Views 395

Constellation Brands Sets New Reporting Date Constellation Brands, Inc. (NYSE: STZ), a prominent player in the beverage alcohol sector, has recently revised its reporting schedule for the financial results of its second quarter, which ended on August 31, 2025. The new reporting date is set for October 6, 2025, after the markets close. Investors and analysts will be able...

Continue Reading
Bullish Trends Continue for Charter Communications in Options Market

Updated Category News Views 212

Analyzing the Recent Options Trends of Charter Communications The options market is bustling with activity around Charter Communications, indicating a strong bullish sentiment. Investors with significant capital are positioning themselves favorably, potentially anticipating upward price movements for the stock, CHTR. Summary of Options Trading Activity Examining the...

Continue Reading
California Water Service Group's Insights on Sustainability Efforts

Updated Category News Views 386

California Water Service Group Advances Sustainability Initiatives In its latest report, California Water Service Group (NYSE: CWT) has unveiled significant progress on various sustainability efforts aimed at minimizing its environmental footprint and enhancing corporate responsibility. This comprehensive overview showcases the Group's dedication to maintaining high...

Continue Reading
Deadline Approaches for Outset Medical Class Action Investors

Updated Category News Views 50

Important Deadline for Outset Medical Investors Investors, it’s time to stay alert! There’s an upcoming deadline that you need to be aware of regarding the class action lawsuit against Outset Medical, Inc. This lawsuit concerns investors who purchased or acquired securities of Outset Medical during a specific period. With the deadline looming, many individuals may be...

Continue Reading
Investors Losing from ASML Holding N.V. Should Seek Justice

Updated Category News Views 145

Investors' Alert: Class Action Against ASML Holding N.V. ASML Holding N.V. (NASDAQ: ASML) is currently facing a class action securities lawsuit that aims to defend the interests of its investors who may have suffered financial losses. This legal move is significant, especially for those who have been adversely affected by certain events within the semiconductor industry....

Continue Reading